Inventor · disambiguated record
Jing Li
Also filed as: LI JING
63 granted patents·52 pending applications·262 citations·filing 2003–2025
98Inventor score
Files withBEIGENE LTD22EISAI R&D MAN CO LTD13CUMBRE PHARMACEUTICALS INC7MERCK SHARP & DOHME7ETERN BIOPHARMA SHANGHAI CO LTD6
Top patents by PatentIndex Score
115 records- 0198US9802953B2Intermediates and methods for the synthesis of halichondrin B analogsEISAI R&D MAN CO LTD·Filed 2016·Granted Oct 31, 2017·15 cites·2 claims
- 0297US10214539B2Intermediates and methods for the synthesis of halichondrin B analogsEISAI R&D MAN CO LTD·Filed 2017·Granted Feb 26, 2019·11 cites·4 claims
- 0397US9604993B2Intermediates and methods for the synthesis of halichondrin B analogsEISAI R&D MAN CO LTD·Filed 2015·Granted Mar 28, 2017·16 cites·11 claims
- 0497US8987479B2Intermediates and methods for the synthesis of halichondrin B analogsCHASE CHARLES·Filed 2011·Granted Mar 24, 2015·46 cites·10 claims
- 0596US8093410B2Intermediates and methods for the synthesis of halichondrin B analogsCHASE CHARLES·Filed 2008·Granted Jan 10, 2012·68 cites·39 claims
- 0692US10322192B2Eribulin-based antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2018·Granted Jun 18, 2019·18 cites·11 claims
- 0790US10947206B2cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2018·Granted Mar 16, 2021·3 cites·46 claims
- 0889US10844079B2Spiro aromatic ring compound and application thereofETERN BIOPHARMA SHANGHAI CO LTD·Filed 2020·Granted Nov 24, 2020·4 cites·2 claims
- 0989US10717743B2Intermediates and methods for the synthesis of halichondrin B analogsEISAI R&D MAN CO LTD·Filed 2019·Granted Jul 21, 2020·2 cites·8 claims
- 1088US10548986B2Eribulin-based antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2017·Granted Feb 4, 2020·9 cites·13 claims
- 1187US11597707B2CGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Granted Mar 7, 2023·1 cites·26 claims
- 1287USRE44987EBromo-phenyl substituted thiazolyl dihydropyrimidinesSUNSHINE LAKE PHARMA CO LTD·Filed 2013·Granted Jul 1, 2014·8 cites·18 claims
- 1385US11220506B2Imidazo[1,5-a]pyrazine derivatives as PI3Kdelta inhibitorsBEIGENE LTD·Filed 2018·Granted Jan 11, 2022·2 cites·22 claims
- 1485US11014906B2Quinoline-based compounds and methods of inhibiting CDK8/19UNIV SOUTH CAROLINA·Filed 2019·Granted May 25, 2021·3 cites·19 claims
- 1585US9808542B2Pyrrolo[2,3-C]pyridines as imaging agents for neurofibrillaryMERCK SHARP & DOHME·Filed 2015·Granted Nov 7, 2017·7 cites·37 claims
- 1685US7238694B2Rifamycin imino derivatives effective against drug-resistant microbesCUMBRE PHARMACEUTICALS INC·Filed 2005·Granted Jul 3, 2007·6 cites·51 claims
- 1784US11685748B2Spiro aromatic ring compound and application thereofETERN BIOPHARMA SHANGHAI CO LTD·Filed 2020·Granted Jun 27, 2023·2 cites·12 claims
- 1884US2025115564A1cGAS ANTAGONIST COMPOUNDSIMMUNESENSOR THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1983US12195449B23-[(1H-pyrazol-r-yl)oxy]pyrazin-2-amine compounds as HPK1 inhibitor and use thereofBEIGENE LTD·Filed 2024·Granted Jan 14, 2025·0 cites·17 claims
- 2083US11136323B2Imidazo[1,5-a]pyrazine derivatives as PI3K δ inhibitorsBEIGENE LTD·Filed 2017·Granted Oct 5, 2021·2 cites·34 claims
- 2181US8236797B2Bromo-phenyl substituted thiazolyl dihydropyrimidinesGOLDMANN SIEGFRIED·Filed 2008·Granted Aug 7, 2012·4 cites·22 claims
- 2281US2024150361A1IMIDAZO[1,5-A]PYRAZINE DERIVATIVES AS PI3Kdelta INHIBITORSBEIGENE LTD·Filed 2024·Application pending·0 cites
- 2380US12065416B2cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2023·Granted Aug 20, 2024·0 cites·32 claims
- 2478US10022461B2Pyrrolo[2,3-C]pyridines as imaging agents for neurofibrilary tanglesMERCK SHARP & DOHME·Filed 2017·Granted Jul 17, 2018·2 cites·3 claims
- 2578US9120855B2Biologic compounds directed against death receptor 5CROMIE KAREN·Filed 2011·Granted Sep 1, 2015·7 cites·17 claims
- 2677US7265107B2Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbesCUMBRE PHARMACEUTICALS INC·Filed 2005·Granted Sep 4, 2007·3 cites·27 claims
- 2777US7202246B2Spiro-rifamycin derivatives targeting RNA polymeraseCUMBRE PHARMACEUTICALS INC·Filed 2005·Granted Apr 10, 2007·3 cites·34 claims
- 2876US8343969B2Bromo-phenyl substituted thiazolyl dihydropyrimidinesSUNSHINE LAKE PHARMA CO LTD·Filed 2012·Granted Jan 1, 2013·3 cites·18 claims
- 2976US2023398228A1Eribulin-based antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2022·Application pending·0 cites
- 3075US9061979B2Mercapto benzophenone compounds, compositions and preparations method thereofINSIGHT HIGH TECHNOLOGY BEIJING CO LTD·Filed 2013·Granted Jun 23, 2015·3 cites·13 claims
- 3174US12441743B2Spiro aromatic ring compound and use thereofETERN BIOPHARMA SHANGHAI CO LTD·Filed 2023·Granted Oct 14, 2025·0 cites·18 claims
- 3274US8507647B2Antibacterial agents for the treatment of gram positive infectionsMETCALF III CHESTER A·Filed 2009·Granted Aug 13, 2013·3 cites·15 claims
- 3374US7247634B2Rifamycin derivatives effective against drug-resistant microbesCUMBRE PHARMACEUTICALS INC·Filed 2005·Granted Jul 24, 2007·3 cites·53 claims
- 3473US11905294B2Imidazo[1,5-a]pyrazine derivatives as PI3Kδ inhibitorsBEIGENE LTD·Filed 2021·Granted Feb 20, 2024·0 cites·23 claims
- 3572US8350059B2Intermediates and methods for making zearalenone macrolide analogsEISAI R&D MAN CO LTD·Filed 2008·Granted Jan 8, 2013·1 cites·24 claims
- 3672US2025236610A13-[(1h-pyrazol-4-yl)oxy]pyrazin-2-amine compounds as hpk1 inhibitor and use thereofBEIGENE LTD·Filed 2025·Application pending·0 cites
- 3772US2020297860A1Eribulin-based antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2019·Application pending·0 cites
- 3871US9434695B2Nitrogenous heterocyclic derivatives and their application in drugsSUNSHINE LAKE PHARMA CO LTD·Filed 2013·Granted Sep 6, 2016·3 cites·15 claims
- 3971US7229996B2Rifamycin derivativesCUMBRE PHARMACEUTICALS INC·Filed 2005·Granted Jun 12, 2007·1 cites·8 claims
- 4071US7226931B2(R/S) rifamycin derivatives, their preparations and pharmaceutical compositionsCUMBRE PHARMACEUTICALS INC·Filed 2005·Granted Jun 5, 2007·1 cites·15 claims
- 4171US2025019408A1Cd40l antagonist and uses thereofVIELA BIO INC·Filed 2024·Application pending·0 cites
- 4269US9458181B2Cathepsin cysteine protease inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Oct 4, 2016·1 cites·15 claims
- 4369US2025136586A1Substituted 7-(Pyrimidin-4-yl)Quinolin-4(1H)-One Compounds as Cyclin Dependent Kinase InhibitorsBEIGENE LTD·Filed 2024·Application pending·0 cites
- 4468US2024300937A1Substituted 6-(Pyrimidin-4-yl)Quinoline Compounds as Cyclin Dependent Kinase InhibitorsBEIGENE LTD·Filed 2024·Application pending·0 cites
- 4568US2025026766A1Thiazolopyridyl Amide Derivatives as DNA Polymerase Theta InhibitorsBEIGENE LTD·Filed 2024·Application pending·0 cites
- 4667US11434246B2EP4 antagonistsEISAI R&D MAN CO LTD·Filed 2021·Granted Sep 6, 2022·0 cites·30 claims
- 4767US2023373963A13-[(1h-pyrazol-r-yl)oxy]pyrazin-2-amine compounds as hpk1 inhibitor and use thereofBEIGENE LTD·Filed 2021·Application pending·0 cites
- 4866US11725012B2Imidazo[1,5-a]pyrazine derivatives as PI3K δ inhibitorsBEIGENE LTD·Filed 2021·Granted Aug 15, 2023·0 cites·28 claims
- 4966US10941148B2EP4 antagonistsEISAI R&D MAN CO LTD·Filed 2019·Granted Mar 9, 2021·0 cites·22 claims
- 5066US10005735B2Inhibitors of RPN11CALIFORNIA INST OF TECHN·Filed 2016·Granted Jun 26, 2018·1 cites·18 claims
Showing the top 50 of 115 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jing Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →